αααααβααΎαBCRX β’ NASDAQ
add
BioCryst Pharmaceuticals Inc
7.80$
αααααααααα(0.018%)-0.0014
7.80$
ααΆααα·αα 31 ααααΌ, 8:00:00 PM ααααβααα -5 · USD · NASDAQ · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·αααΆαααΈααααΆααααΆααααααΆααα
α’αΆαααα·α
αα·αααΈαα»α
7.66$
α
αααααααααααα
7.65$ - 7.83$
α
ααααααα½αααααΆαα
α»αααααα
6.00$ - 11.31$
ααΎαβαα»αβααΈααααΆα
1.64Β αααΈααΆα USD
ααα ααα½αααΌαααααα
3.70Β ααΆα
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
NASDAQ
αααα»αβααααααΆαβ
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 159.40Β ααΆα | 36.14% |
α
αααΆαααααα·ααααα·ααΆα | 83.01Β ααΆα | 27.52% |
α
αααΌααα»ααα | 12.90Β ααΆα | 191.92% |
ααααΆααα
αααααα»ααα | 8.09 | 167.47% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | 0.16 | 328.57% |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 29.93Β ααΆα | 273.93% |
α’ααααΆαααααααααΆαααααα·αααααΆα | -6.34% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 212.87Β ααΆα | -35.50% |
ααααααααα»α | 446.42Β ααΆα | -9.13% |
ααΆαααα½ααα»αααααΌαααα»α | 834.31Β ααΆα | -13.08% |
ααΌαβααααα»α | -387.89Β ααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 210.54Β ααΆα | β |
ααααααααααΉαααααα
| -4.16 | β |
ααα
ααααααΎαααααα | 16.37% | β |
ααα
ααααααΎααΎααα»α | 24.15% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | 12.90Β ααΆα | 191.92% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 41.62Β ααΆα | 404.84% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | 13.57Β ααΆα | 59.88% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -58.81Β ααΆα | -4,716.48% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | -3.87Β ααΆα | -120.51% |
ααα αΌαααΆα
αααααΆααααααα | 30.77Β ααΆα | 43.75% |
α’αααΈ
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China. Wikipedia
ααΆααααααΎαα‘αΎα
1986
ααΆαα·ααΆαααβαααααΆα
αααααβαααααΆα
αα»ααααα·α
580
